Carol Meeske

Publications by Year

Research Areas

RNA Research and Splicing, Monoclonal and Polyclonal Antibodies Research, Developmental Biology and Gene Regulation, RNA and protein synthesis mechanisms, RNA Interference and Gene Delivery

Most-Cited Works

• → H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers(2018)500 cited
• → De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model(2009)40 cited
• → H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies(2016)33 cited
• → 295 (PB283): Predictive Markers of Response to the MDM2 Degrader KT-253(2024)1 cited
• → Supplementary Figure 1, Table 1 from <i>De novo</i> Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel <i>In vivo</i> Breast Tumor Model(2023)
• → Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers(2017)
• → Data from <i>De novo</i> Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel <i>In vivo</i> Breast Tumor Model(2023)